MedTrace Logo

Meibomian Gland Dysfunction Treatment

NCT04229888 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2022-03-29

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the effectiveness of treatments for Meibomian Gland Dysfunction.

Conditions

  • Meibomian Gland Dysfunction
  • Dry Eye

Interventions

DEVICE

LipiFlow

Medical device that applies a combination of heat and pressure to the inner eyelid to remove gland obstructions and stagnant gland content

DEVICE

Light Based (Sham) Treatment

A light based (sham) treatment will be used to compare effectiveness to the LipiFlow treatment.

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-26
Primary Completion
2021-03-25
Completion
2021-03-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04229888 on ClinicalTrials.gov